Trevor M. Jones, Date of Birth, Place of Birth

Trevor M. Jones

professor

Date of Birth: 19-Aug-1942

Place of Birth: Wolverhampton, England, United Kingdom

Profession: academic

Zodiac Sign: Leo

Trevor M Jones, CBE PhD DSc (Hon) FRCP FMedSci FBPhS FRSM FRSC FLSW (born on 19 August 1942) is a visiting professor at King's College London, and a former Head of R&D, at Wellcome.
He continues to have a distinguished career in the pharmaceutical and biotech industry as well as in academia. He was main board director for Research & Development at The Wellcome Foundation Ltd (Wellcome plc).
During his tenure, the organisation was responsible for the development of a number of significant products.
He was not only involved in the introduction of the HIV/AIDS drug AZT at his time with the Wellcome Foundation but also its pricing in the USA/EU and liaison with the South African Government over patents. Jones assisted the Government to attract inward investment into the UK, particularly from the Japanese pharmaceutical companies through the "Prescribe UK" initiative (with Virginia Bottomley and David Sainsbury).
He also led negotiations with the UK Government on the Pharmaceutical Price Regulation Scheme (PPRS) when he was head of the ABPI.
His latest role is advising the Wales Government on the future of the NHS as a member of The Bevan Commission.
He is also a non-executive director of the new life science investment fund, Arix Bioscience Plc and the Oxford based Drug Discovery company, e-Therapeutics plc.